Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNG/EE for Menstrual Cycle-Related Symptoms
NCT00161681Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in premenstrual syndrome (PMS) comparing Levonorgestrel/Ethinyl Estradiol with Placebo (2 arms). Primary endpoint: Efficacy in preventing moderate to severe cycle-related symptoms. Started Jul 2005; status: completed.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on NCT00161681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161681.